CoChat

Essential Medicinal Chemistry of Essential Medicines

Open access

The DOI matches its Crossref record; 66 of the 68 references it cites were found in a registry or an index, and 2 are not checked yet.

Abstract

Since 1977, the World Health Organization publishes a list of essential medicines, i.e., those that satisfy the priority health care needs of the population and are selected with regard to disease prevalence and public health relevance, evidence of clinical efficacy, and safety, as well as comparative costs and cost-effectiveness. The Essential Medicines List (EML) is an invaluable tool for all countries to select those medicines that have an excellent risk/benefit ratio and that are reputed to be of pivotal importance to health. In the present perspective, we describe the chemical composition and the main features of the small molecules that are included in the EML, spanning from their origin, to their stereochemistry and measure of drug-likeness. Most and foremost, we wish to disseminate the importance of the EML, which can be both a helpful teaching tool in an ever-expanding world of medicines and an inspiration for those involved in pharmaceutical R&D.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.0c00415

Cites

66 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart depicting the items on the EML and their exclusion to reach a unique, organic chemistry subset.
Figure 1 Flowchart depicting the items on the EML and their exclusion to reach a unique, organic chemistry subset.CC BY · PubMed Central
Figure 2 Classification of EML organic drugs according to their origin, ATC (1st level) codes, FDA approval year, and route of administration.
Figure 2 Classification of EML organic drugs according to their origin, ATC (1st level) codes, FDA approval year, and route of administration.CC BY · PubMed Central
Figure 3 DT network of all approved drugs (A) and of EMs (B). The DT network is generated by using the known associations between drugs and targets extracted from the DrugBank database.21 As of March 2, 2020, DrugBank (version 5.1.5, released 2020-01-03) includes 2635 approved small molecule drugs and 1367 approved biologics. Additionally, 1148 nonredundant proteins (that are drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Small and big circles correspond to drugs and target proteins, respectively. A link is placed between a drug node and a target node if the protein is a known target of that drug. Drug nodes and connecting links are colored according to the ATC 1st level code of the drug. A bigger representation of the DT network is present in the Supporting Information.
Figure 3 DT network of all approved drugs (A) and of EMs (B). The DT network is generated by using the known associations between drugs and targets extracted from the DrugBank database.21 As of March 2, 2020, DrugBank (version 5.1.5, released 2020-01-03) includes 2635 approved small molecule drugs and 1367 approved biologics. Additionally, 1148 nonredundant proteins (that are drug target/enzyme/transporter/carrier) sequences are linked to these drug entries. Small and big circles correspond to drugs and target proteins, respectively. A link is placed between a drug node and a target node if the protein is a known target of that drug. Drug nodes and connecting links are colored according to the ATC 1st level code of the drug. A bigger representation of the DT network is present in the Supporting Information.CC BY · PubMed Central
Figure 4 Elements beyond CHON present in EMs.
Figure 4 Elements beyond CHON present in EMs.CC BY · PubMed Central
Figure 5 Phosphorus-containing EMs.
Figure 5 Phosphorus-containing EMs.CC BY · PubMed Central
Figure 6 Boron-containing EMs.
Figure 6 Boron-containing EMs.CC BY · PubMed Central
Figure 7 Frequency of selected functional groups found in the EML.
Figure 7 Frequency of selected functional groups found in the EML.CC BY · PubMed Central
Figure 8 Frequency of heterocycles found in the EML. Heterocycles that are present in more than one EM.28
Figure 8 Frequency of heterocycles found in the EML. Heterocycles that are present in more than one EM.28CC BY · PubMed Central
Figure 9 Structures of EMs displaying PAINS.
Figure 9 Structures of EMs displaying PAINS.CC BY · PubMed Central
Figure 10 Represented toxicophorics in the EML. Short-to-medium (s-to-m) chain fatty acids are carboxylic acids bound to a carbon chain with more than 3 atoms.
Figure 10 Represented toxicophorics in the EML. Short-to-medium (s-to-m) chain fatty acids are carboxylic acids bound to a carbon chain with more than 3 atoms.CC BY · PubMed Central
Figure 11 EMs containing a structural alert associated with a BBW due to IADRs. Structural alerts are highlighted in red.
Figure 11 EMs containing a structural alert associated with a BBW due to IADRs. Structural alerts are highlighted in red.CC BY · PubMed Central
Figure 12 Distribution of chiral centers in de novo, nature-inspired, and natural drugs. A more detailed version of Figure 12 is present in the Supporting Information.
Figure 12 Distribution of chiral centers in de novo, nature-inspired, and natural drugs. A more detailed version of Figure 12 is present in the Supporting Information.CC BY · PubMed Central
Figure 13 Structures of the de novo, nature-inspired, and natural drugs that display the highest amount of stereocenters. Stereocenters are highlighted with a blue circle.
Figure 13 Structures of the de novo, nature-inspired, and natural drugs that display the highest amount of stereocenters. Stereocenters are highlighted with a blue circle.CC BY · PubMed Central
Figure 14 Structures of oral EMs that violate two or more of Lipinski’s parameters. Abbreviations: clogP, calculated logP; HBA, hydrogen bond acceptor; HBD, hydrogen bond donor; MW, molecular weight; clogP were extracted using DrugBank21 or ChemSpider42 databases.
Figure 14 Structures of oral EMs that violate two or more of Lipinski’s parameters. Abbreviations: clogP, calculated logP; HBA, hydrogen bond acceptor; HBD, hydrogen bond donor; MW, molecular weight; clogP were extracted using DrugBank21 or ChemSpider42 databases.CC BY · PubMed Central
Figure 15 (A) BBB scores in organic EMs, (B) stratified for their origin, and (C) CNS vs non-CNS drugs.
Figure 15 (A) BBB scores in organic EMs, (B) stratified for their origin, and (C) CNS vs non-CNS drugs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 68 references

Research works printed but not linked: 4

  1. 2020, OMEGA2
  2. Csuk, 2007, Biocatalysis in the Pharma and Biotech Industries, 699
  3. Hutt, 2003, The chiral switch: The development of single enantiomer drugs from racemates, Acta Fac. Pharm. Univ. Comen., 50, 7
  4. 2018, Chemaxon Calculator Plugins

Cited by

See all 48

Metadata

Authors
Serafini, M., Cargnin, S., Massarotti, A., Pirali, T., & Genazzani, A. A.
Affiliations
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT)
Corresponding author
Pirali, Tracey
Venue
Journal of Medicinal Chemistry
Published
2020-04-30
Volume
63
Issue
18
Pages
10170-10187
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3021755458
Cited by
46
References
67
Citations by year
2026: 5 · 2025: 3 · 2024: 12 · 2023: 6 · 2022: 8 · 2021: 9 · 2020: 3
FWCI
1.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Medicinal Chemistry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
Funders
  • Ministero dell???Istruzione, dell???Universit?? e della Ricerca (2017CBNCYT, 2017WJZ9W9)
  • Associazione Italiana per la Ricerca sul Cancro (22568)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Medical and Pharmaceutic Studies
Keywords
essential medicines, WHO Model List of Essential Medicines, small molecules, stereochemistry, drug-likeness, pharmaceutical R&D, drug selection, cost-effectiveness
MeSH terms
Administration, Oral, Chemistry, Pharmaceutical, Formularies as Topic, Humans, Injections, Stereoisomerism, World Health Organization, Molecular Structure, Drugs, Essential

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Essential Medicinal Chemistry of Essential Medicines. https://app.cochat.ai/papers/10.1021/acs.jmedchem.0c00415
The paper
Serafini, M., Cargnin, S., Massarotti, A., Pirali, T., & Genazzani, A. A. (2020). Essential Medicinal Chemistry of Essential Medicines. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.0c00415

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.